J
JNJ
JNJReviewed2 segments tracked|5 years of data|Annual (10-K)
Total Revenue
$94.2B6.0%
FY2025
Operating Segments
2Active segments
Blended Margin
0.0%Operating margin
Highest Margin
0.0%Innovative Medicine
Segment Shift
Innovative Medicine has grown from 0.0% to 64.1% of total revenue since FY2021, with 0.0% operating margins. Meanwhile, Med Tech is the fastest growing at +6.1% YoY.
Segment Revenue Over Time
Revenue Mix
Segment Breakdown — FY2025
| Segment | Revenue | Op. Income | Margin | % of Total | YoY |
|---|---|---|---|---|---|
| Innovative Medicine | $60.4B | $0 | 0.0% | 64.1% | +6.0% |
| Med Tech | $33.8B | $0 | 0.0% | 35.9% | +6.1% |
Want more? Unlock the full analysis.
Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.
Get Started Free